High-Dose Atorvastatin Improves Hypercholesterolemic Coronary Endothelial Dysfunction Without Improving the Angiogenic Response
Munir Boodhwani(University of Ottawa), Frank W. Sellke(Brown University), Roger J. Laham(Beth Israel Deaconess Medical Center), Jun Feng(Brown University), Pierre Voisine(Lung Institute), Jian Li(Beth Israel Deaconess Medical Center), Yasunari Nakai(Beth Israel Deaconess Medical Center), Cesario Bianchi(Cambia Health Solutions (United States)), Shigetoshi Mieno(Beth Israel Deaconess Medical Center), Basel Ramlawi
Cited by 40
Related Papers
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication
|Resuscitation|2008|1.5k
Post–Cardiac Arrest Syndrome
|Circulation|2008|1.4k
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
|New England Journal of Medicine|2017|1.1k
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711